| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets DK Singh, B Singh, SR Ganatra, M Gazi, J Cole, R Thippeshappa, ... Nature microbiology 6 (1), 73-86, 2021 | 171 | 2021 |
| Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. MGBA Maryandyshev A, Pontali E, Tiberi S, Akkerman O, Ganatra S, Sadutshang ... Emerg Infect Dis. 23 (10), 2017 | 62 | 2017 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study O Akkerman, A Aleksa, JW Alffenaar, NH Al-Marzouqi, M Arias-Guillén, ... International journal of infectious diseases 83, 72-76, 2019 | 58 | 2019 |
| Pulmonary Mycobacterium tuberculosis control associates with CXCR3-and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment U Shanmugasundaram, AN Bucsan, SR Ganatra, C Ibegbu, M Quezada, ... JCI insight 5 (14), 2020 | 52 | 2020 |
| Chronic immune activation in TB/HIV co-infection R Sharan, AN Bucşan, S Ganatra, M Paiardini, M Mohan, S Mehra, ... Trends in microbiology 28 (8), 619-632, 2020 | 51 | 2020 |
| Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans EW Tucker, L Pieterse, MD Zimmerman, ZF Udwadia, CA Peloquin, ... Antimicrobial agents and chemotherapy 63 (10), 10.1128/aac. 00913-19, 2019 | 44 | 2019 |
| Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India ZF Udwadia, S Ganatra, JB Mullerpattan European Respiratory Journal 49 (3), 2017 | 40 | 2017 |
| Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model SR Ganatra, AN Bucşan, X Alvarez, S Kumar, A Chatterjee, M Quezada, ... The Journal of clinical investigation 130 (10), 5171-5179, 2020 | 36 | 2020 |
| Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery SE Borisov, L d'Ambrosio, R Centis, S Tiberi, K Dheda, JW Alffenaar, ... Journal of Infection 78 (1), 35-39, 2019 | 36 | 2019 |
| SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species DK Singh, SR Ganatra, B Singh, J Cole, KJ Alfson, E Clemmons, M Gazi, ... BioRxiv, 2020.06. 05.136481, 2020 | 35 | 2020 |
| Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India JB Mullerpattan, ZZ Udwadia, RA Banka, SR Ganatra, ZF Udwadia indian journal of tuberculosis 66 (1), 87-91, 2019 | 33 | 2019 |
| The voltage-gated proton channel Hv1 promotes microglia-astrocyte communication and neuropathic pain after peripheral nerve injury J Peng, MH Yi, H Jeong, PP McEwan, J Zheng, G Wu, S Ganatra, Y Ren, ... Molecular brain 14, 1-18, 2021 | 23 | 2021 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of multidrug and extensively drug-resistant tuberculosis: a multicentre study SE Borisov, K Dheda, M Enwerem, R Romero Leyet, L D’Ambrosio, ... Eur Respir J 49 (5), 1700387, 2017 | 22 | 2017 |
| Visualizing the dynamics of tuberculosis pathology using molecular imaging AA Ordonez, EW Tucker, CJ Anderson, CL Carter, S Ganatra, D Kaushal, ... The Journal of clinical investigation 131 (5), 2021 | 20 | 2021 |
| Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic ZF Udwadia, JA Tornheim, S Ganatra, A DeLuca, CS Rodrigues, A Gupta BMC infectious diseases 19, 1-9, 2019 | 17 | 2019 |
| Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates MA Stammes, JH Lee, L Meijer, T Naninck, LA Doyle-Meyers, AG White, ... Trends in Molecular Medicine 28 (2), 123-142, 2022 | 14 | 2022 |
| Myeloid-derived suppressor cells mediate T cell dysfunction in nonhuman primate TB granulomas B Singh, DK Singh, SR Ganatra, RA Escobedo, S Khader, LS Schlesinger, ... Mbio 12 (6), e03189-21, 2021 | 11 | 2021 |
| members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Surveillance of adverse events in the treatment of drug-resistant … O Akkerman, A Aleksa, JW Alffenaar, NH Al-Marzouqi, M Arias-Guillén, ... Int J Infect Dis 83, 72-6, 2019 | 11 | 2019 |
| Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model R Sharan, SR Ganatra, AN Bucsan, J Cole, DK Singh, X Alvarez, ... The Journal of Clinical Investigation 132 (3), 2022 | 10 | 2022 |
Deepak Kaushal, PhDProfessor and Director, Southwest National Primate Research Center, Texas Biomedical ResearchVerified email at txbiomed.org
